Meta Biomed Co. Ltd Free Cash Flow Generation Index
Meta Biomed Co. Ltd free cash flow generation index. Meta Biomed Co. Ltd (059210) has a Free Cash Flow Generation Index of -3.21x as of September 2025. Free cash flow of ₩-3.38 Billion represents -3% of operating cash flow (₩1.05 Billion).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Meta Biomed Co. Ltd (2011–2024)
Free cash flow generation index of Meta Biomed Co. Ltd from 2011 to 2024. Historical FCF Generation Index trend for Meta Biomed Co. Ltd across 11 annual periods. See Meta Biomed Co. Ltd (059210) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Meta Biomed Co. Ltd Free Cash Flow Generation Index by Year (2011–2024)
Meta Biomed Co. Ltd free cash flow generation index by year from 2011 to 2024. Year-by-year Free Cash Flow Generation Index for Meta Biomed Co. Ltd. For the full cash flow conversion analysis, see 059210 cash flow conversion.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.51x | ₩11.53 Billion | ₩22.63 Billion | ₩11.10 Billion | ▲ +507.7% |
| 2023 | -0.12x | ₩-1.28 Billion | ₩10.22 Billion | ₩11.49 Billion | ▲ +81.7% |
| 2022 | -0.68x | ₩-6.25 Billion | ₩9.16 Billion | ₩15.41 Billion | ▼ -184.0% |
| 2021 | 0.81x | ₩9.04 Billion | ₩11.14 Billion | ₩2.07 Billion | ▲ +154.8% |
| 2020 | 0.32x | ₩1.55 Billion | ₩4.86 Billion | ₩2.23 Billion | ▼ -91.3% |
| 2019 | 3.64x | ₩10.43 Billion | ₩2.86 Billion | ₩7.56 Billion | ▲ +64.1% |
| 2016 | 2.22x | ₩11.16 Billion | ₩5.03 Billion | ₩6.13 Billion | ▼ -14.0% |
| 2015 | 2.58x | ₩12.73 Billion | ₩4.93 Billion | ₩7.79 Billion | ▲ +15.2% |
| 2013 | 2.24x | ₩8.31 Billion | ₩3.71 Billion | ₩4.60 Billion | ▼ -5.6% |
| 2012 | 2.37x | ₩9.09 Billion | ₩3.83 Billion | ₩5.26 Billion | ▼ -21.0% |
| 2011 | 3.00x | ₩12.33 Billion | ₩4.10 Billion | ₩8.22 Billion | — |